Glass Lewis Supports Pro-Dex Board Nominees; Recommends Shareholders Vote For All Nominees on the Company's BLUE PROXY CARD

Glass Lewis Supports Pro-Dex Board Nominees; Recommends Shareholders Vote For
                All Nominees on the Company's BLUE PROXY CARD

FISCAL 2013 SECOND QUARTER FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST

PR Newswire

IRVINE, Calif., Jan. 7, 2013

IRVINE, Calif., Jan. 7, 2013 /PRNewswire/ --PRO-DEX, INC. (Nasdaq: PDEX)
announced today that a report issued on January 3^rd by Glass Lewis & Co., a
leading independent proxy advisory firm serving institutional investors
globally, recommends that shareholders continue to support incumbent
management and the board of Pro-Dex, and vote for all of the Company's board
nominees on the BLUE PROXY CARD at the upcoming Annual Meeting of Shareholders
to be held on January 17, 2013.

(Logo:http://photos.prnewswire.com/prnh/20111025/LA93174LOGO-c)

Michael J. Berthelot, the Company's President and Chief Executive Officer,
commented, "We are pleased that after performing a significant amount of
researchand analysis on the issues, Glass Lewis has recommended that the
incumbent slate of directors be re-elected in the upcoming shareholders
meeting.We believe that the Glass Lewis analysis presents a fair picture of
our Company's challenges and the steps we are taking to move our strategy
forward and build value for all of our shareholders.We urge all of our
shareholders to vote FOR the Company's nominees on the BLUE PROXY CARD."

Mr. Berthelot also noted that "While we are disappointed that ISS did not
reach the same conclusion, we note that, in spite of what AO Group implied in
a recent press release, ISS did not recommend that all of their candidates be
elected and specifically advised that shareholders should withhold their votes
for one of the AO candidates. ISS concluded that 'support for a controlling
slate is not justified.' We are disappointed that the AO Group would
mischaracterize the ISS conclusion."

"It is not too late to vote using the BLUE PROXY CARD," Mr. Berthelot
continued."Even if you have already voted, you may change your vote to one in
support of the incumbent directors by voting the BLUE PROXY CARD on-line at
www.proxyvote.com, by telephone at 1-800-690-6903, or by mail to Vote
Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.If you have
any questions about the voting process, please do not hesitate to call our
proxy solicitor, AST Phoenix Advisors, toll-free at 1-877-721-1318.We
appreciate your support, and pledge to do our best to build value for all of
our shareholders."

Fiscal 2013 Second Quarter Financial Results Conference Call and Webcast

Pro-Dex invites investors and analysts to participate in management's
broadcast review of the Company's fiscal 2013 second quarter financial
results.

The conference call is scheduled to be broadcast live over the internet on
Thursday, January 10, 2013 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)
and may be accessed by visiting the Company's website at www.pro-dex.com and
selecting the "Investor Relations" page. The conference call may also be
accessed at www.InvestorCalendar.com.Investors and analysts who would like to
participate in the conference call may do so via telephone at (877) 407-8033,
or at (201) 689-8033 if calling from outside the U.S. or Canada.

For those who cannot access the live broadcast, a replay will be available
from approximately two hours after the completion of the call until midnight
(Eastern Time) on January 24, 2013 by calling (877) 660-6853, or (201)
612-7415 if calling from outside the U.S. or Canada, and then entering
conference I.D. number 407053. An online archive of the broadcast will be
available on the Company's website at www.pro-dex.com, on the "Investor
Relations" page, for one year.

About Pro-Dex, Inc.:

Pro-Dex, Inc., with operations in California and Oregon, specializes in the
design, development and manufacture of powered rotary drive surgical and
dental instruments used primarily in the orthopedic, spine, maxocranial facial
and dental markets.Its OMS division designs and manufactures embedded motion
control systems serving the medical, dental, semi-conductor and scientific
research markets. Pro-Dex's products are found in hospitals, dental offices,
medical engineering labs, scientific research facilities and high tech
manufacturing operations around the world. For more information, visit the
Company's website at www.pro-dex.com.

Statements herein concerning the Company's plans, growth and strategies may
include 'forward-looking statements' within the context of the federal
securities laws. Statements regarding the Company's future events,
developments and future performance, as well as management's expectations,
beliefs, plans, estimates or projections relating to the future, are
forward-looking statements within the meaning of these laws. The Company's
actual results may differ materially from those suggested as a result of
various factors. Interested parties should refer to the disclosure concerning
the operational and business concerns of the Company set forth in the
Company's filings with the Securities and Exchange Commission.

SOURCE Pro-Dex, Inc.

Website: http://www.pro-dex.com
Contact: Michael J. Berthelot, Chief Executive Officer, +1-949-769-3200
 
Press spacebar to pause and continue. Press esc to stop.